Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This study will determine if NXY-059 is safe in patients with an acute stroke caused by
bleeding in the central nervous system. The primary objective was to assess the safety and
tolerability of NXY-059 compared to placebo.